ALB and cancer: The importance of albumin as a nutrient source for tumors, combined with the knowledge that cancer patients are frequently hypoalbuminemic [5], suggests that in the absence of oncogenic Ras mutations such tumors may have alterations in other pathways to enable increased albumin delivery to degradative compartments.